Category Archives: CEO

Jeanmarie Guenot – Leading The Amphivena Therapeutics Inc To Success Through Exemplary Leadership Skills

Jeanmarie Guenot is one of the most renowned personalities in the field of biotechnology and biopharmaceuticals and has an extensive experience of over two decades. Over the career spanning more than twenty years, Jeanmarie has worked with numerous companies in both public and private domain. At present, Jeanmarie serves as the President and Chief Executive Officer of Amphivena Therapeutics Inc, a firm that is focused on immune therapies research and finding effective diagnose for blood cancers. The company is headquartered in San Francisco, and even though it is under pre-clinical development stage, the firm aims to provide an efficient cure for hematological malignancies, blood cancer, and tumors.

Jeanmarie’s experience over the years has broadened her skills and expertise portfolio, which now includes pharmaceutical research and development, business development, project management, commercial product portfolio, alliance management, licensing, client management, venture capital, corporate development, merger and acquisitions, scientific collaborations, and more reported on amphivena.com. During her career span of over twenty years, Jeanmarie has had an opportunity to work in most of the major therapeutic areas. She did her Masters in Business Administration from University of Pennsylvania’s Wharton School of Business and Ph.D. from University of California, San Francisco.

Jeanmarie Guenot joined Hoffman-La Roche after completing her studies as a team leader and principal scientist, handling Preclinical research and development. After working for six years for Hoffman-La Roche, she joined Atlas Venture as an associate in the Life Sciences department, and it is where her business expertise flourished as she looked for lucrative biotech firms to invest in and acquire. After leaving Atlas Venture, Jeanmarie joined PDL BioPharma as Vice President of Corporate and Business Development and even started her company named Guenot LLC in 2008, which provided business consulting services in the biotechnology and pharmaceutical sector on BusinessWire.com.

Jeanmarie is also the founder of SKS Ocular, LLC, a biotechnology startup that aims at improving cancer therapies and finding an innovative cure for hematological malignancies, macular degeneration, and glaucoma. She has won many awards at https://www.takeda.com/news/2017/20170111_7659.html during her career span, which includes Deal of Distinction Award by Licensing Executives Society and Innovative Bio-Partnering Award by BioBusiness Network. Jeanmarie Guenot continues to be enterprising in the biotechnology sector to help take Amphivena Therapeutics collaborate, grow and expand, to achieve its mission of finding effective cancer therapies successfully.

Maggie Gill Becomes A CEO To Know

Maggie Gill received her undergraduate degree from Florida State University and a MBA at Saint Leo University. After graduation, she spent five years with Tenet South Florida Health System as its Chief Financial Officer (CFO). During that time she worked at the North Shore Medical Center in Miami, the Palmetto General Hospital in Hialeah, and the Coral Gables Hospital in Coral Gables. Maggie Gill received the Tenet Outstanding CFO award three times during her five years there.

After leaving an impression on Tenet, Maggie Gill moved on to join the Memorial University Medical Center (MUMC) as their Vice President of finance/managed care in 2004. Just one year later, she became the company’s Chief Operation Officer, and was named President and CEO of Memorial Health in 2011.

 

As President and CEO of MUMC, Maggie Gill is responsible for providing leadership to all of the company’s executives, including physician leaders, vice presidents, and senior vice presidents. Her responsibilities also include directing government relations, physician relations, financial assistance, corporate communications, and facilities management. She is also in charge of MUMC’s internal audit, Memorial Health University Physicians (MHUP), the Heart & Vascular Institute, orthopedic and neuroscience programs, trauma services, and perioperative services.

 

In 2016, Maggie Gill received a coveted award from the Becker’s Hospital Review, one of the country’s largest sources for information for healthcare leaders. As a monthly publication, it holds a current audience of 18,500 healthcare field leaders. Maggie Gill was listed on the review’s list of “135 Nonprofit Hospital and Health System CEOs to Know.” She was also included on the review’s 2016 list of “130 Women Hospital and Health System Leaders to Know.”

 

The Memorial University Medical Center was opened in 1955 and has turned into one of the most advanced healthcare providers in the entire area. This medical center was earned many local and national awards, priding themselves on their healthcare public policy and patient safety. MUMC is part of the Memorial Health system, which currently serves more than 35 counties across the states of Georgia and South Carolina. In addition to their hundreds of thousands of patients they serve each year, MUMC is one of the most charitable healthcare providers in the entire state.